Browse > Article
http://dx.doi.org/10.3904/kjim.2011.26.1.34

Prognostic Factors Associated with Survival in Patients with Primary Duodenal Adenocarcinoma  

Chung, Woo-Chul (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Paik, Chang-Nyol (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Jung, Sung-Hoon (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Lee, Kang-Moon (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Kim, Sang-Woo (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Chang, U-Im (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Yang, Jin-Mo (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Publication Information
The Korean journal of internal medicine / v.26, no.1, 2011 , pp. 34-40 More about this Journal
Abstract
Background/Aims: The prognostic factors in primary duodenal adenocarcinoma remain controversial. This study evaluated the prognostic factors associated with survival in patients with primary duodenal adenocarcinoma. Methods: From March 1996 to June 2008, the medical records of 30 patients with a final diagnosis of primary duodenal epithelial malignancy seen at two referral centers were reviewed retrospectively. The prognostic factors for survival were evaluated 6 months and 1, 2, and 5 years after the diagnosis. Results: The median survival was 5.7 months. The survival rate was 46.7% (14/30), 16.7% (5/30), 10% (3/30), and 6.7% (2/30) at 6 months and 1, 2, and 5 years, respectively. Multivariate analysis showed that cancer-directed treatment, including curative surgery or chemotherapy, was a common independent risk factor at all follow-up times. Total bilirubin, cytology, and TNM stage were independent risk factors for survival at 1, 2, and 5 years. The white blood cell count was an independent risk factor at 1 year only. The actuarial probability of survival in patients undergoing cancer-directed treatment was significantly higher than in those without treatment at 6 months (71.4 vs. 25.0%, p < 0.01), 1 year (28.6 vs. 6.3%, p < 0.01), 2 years (21.4 vs. 0%, p < 0.01), and 5 years (14.3 vs. 0%, p < 0.01). Conclusions: The prognostic factors in patients with primary duodenal adenocarcinoma were total bilirubin, TNM stage, cytology, and cancer-directed treatments until the 5-year follow-up. Especially, cancer-directed treatments improved patient survival.
Keywords
Duodenal cacner; Prognosis; Cancer-directed treatment;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Spira IA, Ghazi A, Wolff WI. Primary adenocarcinoma of the duodenum. Cancer 1977;39:1721-1726.   DOI   ScienceOn
2 Bucher P, Gervaz P, Morel P. Long-term results of radical resection for locally advanced duodenal adenocarcinoma. Hepatogastroenterology 2005;52:1727-1729.
3 Lillemoe K, Imbembo AL. Malignant neoplasms of the duodenum. Surg Gynecol Obstet 1980;150:822-826.
4 Moss WM, McCart PM, Juler G, Miller DR. Primary adenocarcinoma of the duodenum. Arch Surg 1974;108:805-807.   DOI   ScienceOn
5 Pitt HA. Duodenal cancer: endoscopic or surgical resection? J Clin Gastroenterol 2003;37:356-357.   DOI   ScienceOn
6 Rose DM, Hochwald SN, Klimstra DS, Brennan MF. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg 1996;183:89-96.
7 Hung FC, Kuo CM, Chuah SK, et al. Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience. J Gastroenterol Hepatol 2007;22:724-728.   DOI   ScienceOn
8 Bal A, Joshi K, Vaiphei K, Wig JD. Primary duodenal neoplasms: a retrospective clinico-pathological analysis. World J Gastroenterol 2007;13:1108-1111.   DOI
9 Lee CC, Ng WK, Lin KW, Lai TW, Li SM. Adenocarcinoma of the duodenum. Hong Kong Med J 2008;14:67-69.
10 Gonzalez GD, Evans EC. Primary adenocarcinoma of the duodenum. Am Surg 1987;53:174-179.
11 Agrawal S, McCarron EC, Gibbs JF, Nava HR, Wilding GE, Rajput A. Surgical management and outcome in primary adenocarcinoma of the small bowel. Ann Surg Oncol 2007;14:2263-2269.   DOI   ScienceOn
12 Bakaeen FG, Murr MM, Sarr MG, et al. What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 2000;135:635-641.   DOI   ScienceOn
13 Hu JX, Miao XY, Zhong DW, Dai WD, Liu W, Hu W. Surgical treatment of primary duodenal adenocarcinoma. Hepatogastroenterology 2006;53:858-862.
14 Sohn TA, Lillemoe KD, Cameron JL, et al. Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg 1998;2:79-87.   DOI   ScienceOn
15 Barnes G Jr, Romero L, Hess KR, Curley SA. Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1994;1:73-78.   DOI   ScienceOn
16 Lee HG, You DD, Paik KY, Heo JS, Choi SH, Choi DW. Prognostic factors for primary duodenal adenocarcinoma. World J Surg 2008;32:2246-2252.   DOI   ScienceOn
17 Rotman N, Pezet D, Fagniez PL, Cherqui D, Celicout B, Lointier P. Adenocarcinoma of the duodenum: factors influencing survival. French Association for Surgical Research. Br J Surg 1994;81:83-85.   DOI   ScienceOn
18 Sexe RB, Wade TP, Virgo KS, Johnson FE. Incidence and treatment of periampullary duodenal cancer in the U.S. veteran patient population. Cancer 1996;77:251-254.   DOI   ScienceOn
19 Santoro E, Sacchi M, Scutari F, Carboni F, Graziano F. Primary adenocarcinoma of the duodenum: treatment and survival in 89 patients. Hepatogastroenterology 1997;44:1157-1163.
20 Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 2004;101:518-526.   DOI   ScienceOn
21 Brucher BL, Stein HJ, Roder JD, et al. New aspects of prognostic factors in adenocarcinomas of the small bowel. Hepatogastroenterology 2001;48:727-732.
22 Locher C, Malka D, Boige V, et al. Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology 2005;69:290-294.   DOI   ScienceOn
23 Stell D, Mayer D, Mirza D, Buckels J. Delayed diagnosis and lower resection rate of adenocarcinoma of the distal duodenum. Dig Surg 2004;21:434-438.   DOI   ScienceOn